November 12, 2019
- FDA Drug Shortages
- Atropine Sulfate Injection (Updated - Currently in Shortage)
- Bupivacaine Hydrochloride and Epinephrine Injection, USP (Updated - Currently in Shortage)
- Cefotetan Disodium Injection (Updated - Currently in Shortage)
- Cefoxitin for Injection, USP (Updated - Currently in Shortage)
- Dexrazoxane Injection (Updated - Currently in Shortage)
- Eptifibatide (Integrilin) Injection (New - Discontinuation)
- Flurazepam Hydrochloride Capsules (Updated - Currently in Shortage)
- Hydromorphone Hydrochloride Injection, USP (Updated - Currently in Shortage)
- Ketorolac Tromethamine Injection (Updated - Currently in Shortage)
- Leucovorin Calcium Lyophilized Powder for Injection (Updated - Currently in Shortage)
- Levetiracetam Immediate-Release Oral Tablets, USP (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine (Updated - Currently in Shortage)
- Morphine Sulfate Injection, USP (Updated - Currently in Shortage)
- Ondansetron Hydrochloride Injection (Updated - Currently in Shortage)
- Oxytocin Injection, USP Synthetic (Updated - Currently in Shortage)
- Pantoprazole Sodium for Injection (Updated - Currently in Shortage)
- Quinapril Hydrochloride (Accupril) Tablets (New - Discontinuation)
- Ropivacaine Hydrochloride Injection (Updated - Currently in Shortage)
- Sodium Acetate Injection, USP (Updated - Currently in Shortage)
- Sodium Chloride 23.4% Injection (Updated - Currently in Shortage)
- Tacrolimus Capsules (Updated - Currently in Shortage)
- Thiothixene Capsules (Updated - Currently in Shortage)
- Vinblastine Sulfate Injection (Updated - Currently in Shortage)
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Drugs@FDA Data Files (updated)
- National Drug Code Directory (updated)
- NDC Database Excluded Packages and Products (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario